Use of dicarboxylic acids in type 2 diabetes

British Journal of Clinical Pharmacology

Volumn 75, Issue 3, 2013, Pages 671-676

  Mingrone, Geltrude ^a   Castagneto Gissey, Lidia ^a   Macé, Katherine ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Dicarboxylic acids; Dodecanedioic acid; Sebacic acid; Type 2 diabetes

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CITRATE SYNTHASE; DICARBOXYLIC ACID DERIVATIVE; DODECANEDIOIC ACID; GLUCOSE TRANSPORTER 4; INSULIN; METHYLMALONYL COENZYME A CARBOXYLTRANSFERASE; OXOGLUTARATE DEHYDROGENASE; SEBACIC ACID; TEGLICAR; TRIACYLGLYCEROL; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; DIABETES MELLITUS; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOGEN MUSCLE LEVEL; HUMAN; INSULIN SENSITIVITY; LIPID TRANSPORT; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; STRUCTURE ACTIVITY RELATION; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; DECANOIC ACIDS; DIABETES MELLITUS, TYPE 2; DICARBOXYLIC ACIDS; GLUCONEOGENESIS; HUMANS; INSULIN RESISTANCE; MUSCLE FATIGUE; NUTRITIVE VALUE;

EID: 84873451526     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04177.x     Document Type: Article

References (48)

1. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010; 1801: 209-14.
2. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006; 6: 177-81.
3. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr 2002; 22: 325-46.
4. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, Vettor R, Gasbarrini G, Greco AV. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 2002; 26: 1165-72.
5. Krssak M, Petersen KF, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999; 42: 113-6.
6. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-71.
7. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007; 56: 1376-81.
8. Zorzano A, Liesa M, Palacín M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol 2009; 41: 1846-54.
9. Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89: 799-845.
10. Zorzano A, Liesa M, Palacín M. Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch Physiol Biochem 2009; 115: 1-12.
11. Storlien L, Oakes ND, Kelley DE. Metabolic flexibility. Proc Nutr Soc 2004; 63: 363-8.
12. Mingrone G, Manco M, Calvani M, Castagneto M, Naon D, Zorzano A. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia 2005; 48: 2108-14.
13. Gaster M. Reduced TCA flux in diabetic myotubes. A governing influence on the diabetic phenotype? Biochem Biophys Res Commun 2009; 387: 651-5.
14. Bertuzzi A, Mingrone G, Gandolfi A, Greco AV, Salinari S. Disposition of dodecanedioic acid in humans. J Pharmacol Exp Ther 2000; 292: 846-52.
15. Mingrone G, De Gaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G. Comparison between dodecanedioic acid and long-chain triglycerides as an energy source in liquid formula diets. JPEN J Parenter Enteral Nutr 1999; 23: 80-4.
16. Mingrone G, De Gaetano A, Greco AV, Benedetti G, Capristo E, Castagneto M, Gasbarrini G. Plasma clearance and oxidation of dodecanedioic acid in humans. JPEN J Parenter Enteral Nutr 1996; 20: 38-42.
17. Greco AV, Mingrone G. Dicarboxylic acids, an alternate fuel substrate in parenteral nutrition: an update. Clin Nutr 1995; 14: 143-8.
18. Raguso CA, Mingrone G, Greco AV, Tataranni PA, De Gaetano A, Castagneto M. Dicarboxylic acids and glucose utilization in humans: effect of sebacate. JPEN J Parenter Enteral Nutr 1994; 18: 9-13.
19. Mingrone G, Greco AV, Castagneto M, De Gaetano A, Tataranni PA, Raguso C. Kinetics and thermogenesis of medium-chain monocarboxylic and dicarboxylic acids in man: sebacate and medium-chain triglycerides. JPEN J Parenter Enteral Nutr 1993; 17: 257-64.
20. Mingrone G, Tacchino RM, Castagneto M, Finotti E, Greco AV. Use of even-numbered carbon atom dicarboxylic salts in parenteral nutrition as fuel substrate. JPEN J Parenter Enteral Nutr 1992; 16: 32-8.
21. Greco AV, Mingrone G, Raguso C, Tataranni A, Finotti E, Tacchino RM, Capristo E, De Gaetano A, Castagneto M. Metabolic effects and disposition of sebacate, an alternate dicarboxylic fuel substrate. Ann Nutr Metab 1992; 36: 1-11.
22. Mingrone G, Greco AV, Bertuzzi A, Arcieri-Mastromattei E, Tacchino RM, Marino F, Finotti E, Castagneto M. Tissue uptake and oxidation of disodium sebacate in man. JPEN J Parenter Enteral Nutr 1991; 15: 454-9.
23. Verkade PE, Van der Lee J. Researches on fat metabolism II. Biochem J 1934; 28: 31-40.
24. Kolattukudy PE, Walton TJ, Kushwaha RP. Biosynthesis of the C18 family of cutin acids: omega-hydroxyoleic acid, omega-hydroxy-9, 10-epoxystearic acid, 9, 10, 18-trihydroxystearic acid, and their delta12-unsaturated analogs. Biochemistry 1973; 12: 4488-98.
25. Kolattukudy PE. Polyesters in higher plants. Adv Biochem Eng Biotechnol 2001; 71: 1-49.
26. Penfield S, Graham S, Graham IA. Storage reserve mobilization in germinating oilseeds: Arabidopsis as a model system. Biochem Soc Trans 2005; 33: 380-3.
27. Moutsatsou P, Papoutsi Z, Kassi E, Heldring N, Zhao C, Tsiapara A, Melliou E, Chrousos GP, Chinou I, Karshikoff A, Nilsson L, Dahlman-Wright K. Fatty Acids Derived from Royal Jelly Are Modulators of Estrogen Receptor Functions. PLoS ONE 2010; 5: e15594.
28. Kolvraa S, Gregersen N. In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. Biochim Biophys Acta 1986; 876: 515-25.
29. Nilsson A, Arey H, Pedersen JI etal. The effect of high-fat diets on microsomal lauric acid hydroxylation in rat liver. Biochim Biophys Acta 1986; 879: 209-14.
30. Shet M, Fisher CW, Holmans PL, Estabrook RW. The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase. Arch Biochem Biophys 1996; 330: 199-208.
31. Mortensen PB. C6-C10-dicarboxylic aciduria in starved, fat-fed and diabetic rats receiving decanoic acid or medium-chain triacylglycerol. An in vivo measure of the rate of beta-oxidation of fatty acids. Biochim Biophys Acta 1981; 664: 349-55.
32. Kølvraa S, Gregersen N. In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. Biochim Biophys Acta 1986; 876: 515-25.
33. Liu G, Hinch B, Beavis AD. Mechanisms for the transport of alpha, omega-dicarboxylates through the mitochondrial inner membrane. J Biol Chem 1996; 271: 338-44.
34. Greco AV, Mingrone G, Arcieri Mastromattei E, Finotti E, Castagneto M. Toxicity of disodium sebacate. Drugs Exp Clin Res 1990; 16: 531-6.
35. Bertuzzi A, Finotti E, Mingrone G, Greco AV. Sebacic acid binding to human plasma albumin. Biochem Pharmacol 1993; 45: 697-702.
36. de Gaetano A, Mingrone G, Castagneto M, Benedetti G, Greco AV, Gasbarrini G. Kinetics of dodecanedioic acid triglyceride in rats. Am J Physiol 1999; 276: E497-502.
37. Membrez M, Chou CJ, Raymond F, Mansourian R, Moser M, Monnard I, Ammon-Zufferey C, Mace K, Mingrone G, Binnert C. Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice. Diabetes Obes Metab 2010; 12: 1120-6.
38. Turk D, Alzaid AA, Dinneen SF, Nair KS, Rizza RA. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 1995; 95: 755-62.
39. Gómez-Valadés AG, Méndez-Lucas A, Vidal-Alabró A, Blasco FX, Chillon M, Bartrons R, Bermúdez J, Perales JC. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 2008; 57: 2199-210.
40. Fujiwara T, Okuno A, Yoshioka S, Horikoshi H. Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice. Metabolism 1995; 44: 486-90.
41. Conti R, Mannucci E, Pessotto P, Tassoni E, Carminati P, Giannessi F, Arduini A. Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis. Diabetes 2011; 60: 644-51.
42. Iaconelli A, Gastaldelli A, Chiellini C, Gniuli D, Favuzzi A, Binnert C, Macé K, Mingrone G. Effect of oral sebacic Acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes. Diabetes Care 2010; 33: 2327-32.
43. Casey A, Short AH, Curtis S, Greenhaff PL. The effect of glycogen availability on power output and the metabolic response to repeated bouts of maximal, isokinetic exercise in man. Eur J Appl Physiol Occup Physiol 1996; 72: 249-55.
44. Broberg S, Sahlin K. Hyperammoniemia during prolonged exercise: an effect of glycogen depletion? J Appl Physiol 1988; 65: 2475-7.
45. Hermansen L, Hultman E, Saltin B. Muscle glycogen during prolonged severe exercise. Acta Physiol Scand 1967; 71: 129-39.
46. Bergstrom J, Hultman E. Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man. Nature 1966; 210: 309-10.
47. Panagiotis H, Short KR, Bigelow M, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002; 51: 2395-404.
48. Salinari S, Bertuzzi A, Gandolfi A, Greco AV, Scarfone A, Manco M, Mingrone G. Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects. Am J Physiol Endocrinol Metab 2006; 291: E1051-8.